Global Chiropody & Podiatry Market Size By Type (Surgery Practices, Physiotherapy), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Chiropody & Podiatry Market was valued at USD 7.1 billion in 2023 and is expected to surpass USD 12.6 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2023 to 2031. The market is experiencing robust growth due to rising awareness around foot health, the increasing prevalence of diabetes and arthritis, and growing demand for non-invasive treatments in orthotic and geriatric care. Advancements in podiatric devices and digital diagnostics are also fueling market expansion.

Drivers:

1. Rising Prevalence of Diabetes and Foot Disorders

The growing global diabetic population is a significant factor driving demand for chiropody and podiatry services. Diabetic foot ulcers, neuropathy, and infections require consistent podiatric care, pushing growth across both developed and developing nations.

2. Aging Population and Geriatric Foot Care

The increase in the elderly population is fueling demand for specialized foot care services. Conditions such as osteoarthritis, bunions, and mobility issues among the elderly contribute to the rising adoption of podiatric treatments and orthotics.

3. Technological Advancements in Diagnosis and Treatment

Innovation in 3D foot scanning, smart insoles, and minimally invasive surgical procedures is transforming the market. These technologies provide faster, more accurate diagnostics and enhanced patient comfort, supporting wider adoption.

Restraints:

1. High Cost of Specialized Treatments

Podiatric treatments, particularly those involving surgical procedures or custom orthotics, can be costly, limiting accessibility for certain patient groups, particularly in low-income regions.

2. Lack of Awareness in Emerging Markets

Despite increasing demand, limited awareness about the importance of preventive foot care in some parts of Asia-Pacific and Africa remains a hurdle to broader market penetration.

Opportunity:

1. Integration of Telehealth and Digital Health Platforms

The adoption of telepodiatry—virtual consultations for foot and ankle disorders—has increased post-pandemic and is enabling access to care in rural and underserved areas.

2. Expansion into Emerging Economies

Emerging markets such as India, Brazil, and Southeast Asia present strong growth opportunities due to improving healthcare infrastructure, a rising diabetic population, and increasing health consciousness.

3. Growing Sports Injury Management Sector

Rising participation in recreational and professional sports has led to increased cases of ankle sprains, stress fractures, and plantar fasciitis, creating strong demand for podiatric interventions.

Market by System Type Insights:

Based on system type, the Orthotic Devices segment dominated the global chiropody & podiatry market in 2023. These devices, including insoles and ankle-foot orthoses, are widely used for managing biomechanical foot disorders. The segment’s growth is driven by increasing demand for customized, 3D-printed orthotics offering better comfort and performance.

The Therapeutic Devices segment is expected to witness the highest CAGR during the forecast period, supported by innovations in ultrasound therapy, shockwave therapy, and laser treatment systems used in podiatric care.

Market by End-use Insights:

In terms of end-use, Hospitals & Specialty Clinics accounted for the largest market share in 2023. This dominance is due to their capacity to offer a wide range of podiatric treatments under one roof, including diagnostics, surgery, and rehabilitation.

The Homecare Settings segment is anticipated to grow rapidly as the demand for remote monitoring, foot care kits, and self-managed orthotic treatments continues to rise—especially among elderly and mobility-challenged patients.

Market by Regional Insights:

North America held the largest share of the global chiropody & podiatry market in 2023, owing to a high prevalence of diabetes, developed healthcare systems, and strong insurance coverage for podiatric treatments. The region also benefits from widespread awareness and availability of advanced podiatric technologies.

Asia-Pacific is projected to experience the fastest growth over the forecast period. Rising income levels, growing healthcare expenditure, increasing incidence of chronic foot conditions, and expanding geriatric demographics are fueling regional market growth.

Competitive Scenario:

Key players in the global chiropody & podiatry market include Dr. Comfort (part of DJO Global), OrthoFeet, Bauerfeind AG, Algeos, Össur, Hanger Inc., Foot Science International, and Breg, Inc. These companies are actively investing in product development, regional expansion, and strategic collaborations to enhance their market share.

Recent Developments:

In 2024, OrthoFeet launched a new line of diabetic shoes integrated with smart temperature and pressure sensors for real-time monitoring.

In 2023, Bauerfeind AG introduced a range of eco-friendly orthotic insoles made from sustainable materials.

In 2023, Hanger Inc. partnered with digital health startups to implement remote podiatric assessment tools in U.S.-based clinics.

Scope of Work – Global Chiropody & Podiatry Market

Report Metric Details

Market Size (2023) USD 7.1 billion

Projected Market Size (2031) USD 12.6 billion

CAGR (2023–2031) 7.4%

Market Segments System Type (Orthotic Devices, Therapeutic Devices), End-use, Region

Growth Drivers Rising diabetes cases, aging population, advances in treatment options

Opportunities Telepodiatry, emerging markets, sports injury management

Key Market Developments:

2024: OrthoFeet launches AI-powered 3D foot scanning for custom orthotics.

2023: Foot Science International partners with hospitals in Southeast Asia to deliver cost-effective podiatric devices.

2023: Breg, Inc. introduces a mobile application for patient engagement in podiatric rehab programs.

FAQs:

1) What is the current market size of the Global Chiropody & Podiatry Market?

The market size in 2023 was valued at USD 7.1 billion.

2) What is the major growth driver of the Global Chiropody & Podiatry Market?

Rising cases of diabetes and increased focus on preventive foot care are the major growth drivers.

3) Which is the largest region during the forecast period in the Global Chiropody & Podiatry Market?

North America remains the largest region due to a high prevalence of foot-related chronic conditions and advanced healthcare infrastructure.

4) Which segment accounted for the largest market share in Global Chiropody & Podiatry Market?

The Orthotic Devices segment held the largest market share in 2023.

5) Who are the key market players in the Global Chiropody & Podiatry Market?

Key players include Dr. Comfort, OrthoFeet, Bauerfeind AG, Algeos, Össur, Hanger Inc., and Foot Science International.